|
1. Bellas RE, FitzGerald MJ, Fausto N, Sonenshein GE. 1997. Inhibition of NF-kappa B activity induces apoptosis in murine hepatocytes. Am. J. Pathol. 151:891-896. 2. Collier L and Oxford J. 1993. Human Virology. Oxford University Press, New York. pp251-267. 3. Chung MK, Yoon H, Min SS, Lee HG, Kim YJ, Lee TG, Lim JS, Kim CM, Park SN. 1999. Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in hepatitis B virus X antigen. J. Immunother. 22:279-287. 4. Feitelson MA, Duan LX, Guo J, Sun B, Woo J, Steensma K, Horiike N, Blumberg BS. 1995. X region deletion variants of hepatitis B virus in surface antigen-negative infections and non-A, non-B hepatitis. J. Infect. Dis. 172:713-722. 5. Feitelson MA, Ranganathan PN, Clayton MM, Zhang SM. 1997. Partial characterization of the woodchuck hepatitis virus X antigen in hepatocarcinogenesis. Oncogene 15:327-336. 6. Galibert F, Mandart E, Fitoussi F, Tiollais P, Charnay P. 1979. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 281:646-650. 7. Gottlob K, Pagano S, Levrero M, Graessmann A. 1998. Hepatitis B virus X protein transcription activation domains are neither required nor sufficient for cell transformation. Cancer Res. 58:3566-3570. 8. Hosono S, Tai PC, Wang W, Ambrose M, Hwang DG, Yuan TT, Peng BH, Yang CS, Lee CS, Shih C. 1995. Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes. Virology 212:151-162. 9. Jung MC, Stemler M, Weimer T, Spengler U, Dohrmann J, Hoffmann R, Eichenlaub D, Eisenburg J, Paumgartner G, Riethmuller G. 1991. Immune response of peripheral blood mononuclear cells to HBx-antigen of hepatitis B virus. Hepatology 13:637-643. 10. Kasai Y, Takeda S, Takagi H. 1996. Pathogenesis of hepatocellular carcinoma: a review from the viewpoint of molecular analysis. Semin. Surg. Oncol. 12:155-156. 11. Kim H, Lee H, Yun Y. 1998. X-gene product of hepatitis B virus induces apoptosis in liver cells. J. Biol. Chem. 273:381-385. 12. Koike K, Moriya K, Iino S, Yotsuyanagi H, Endo Y, Miyamura T, Kurokawa K. 1994. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 19:810-819. 13. Koike K, and Takada S. 1995. Biochemistry and functions of hepatitis B virus X protein. Intervirology 38:89-99. 14. Levy JA, Heinz FC, Robert AO. 1994. Virology. Prentic Hall, England. pp143-146. 15. Lin Y, Tang H, Nomura T, Dorjsuren D, Hayashi N, Wei W, Ohta T, Roeder R, Murakami S. 1998. The hepatitis B virus X protein is a co-activator of activated transcription that modulates the transcription machinery and distal binding activators. J. Biol. Chem. 273:27097-27103. 16. Marion PL, Oshiro L, Regnery DC, Scullard GH, Robinson WS. 1980. A virus in Beechey ground squirrels that is related to hepatitis B virus of man. Proc. Natl. Acad. Sci. USA. 77:2941-2945. 17. Mason WS, Seal G, Summers J. 1980. Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. J. Virol. 62:3832-3839. 18. Menzo S, Clementi M, Alfani E, Bagnarelli P, Iacovacci S, Manzin A, Dandri M, Natoli G, Levreo M, Carloni G. 1993. Transactivation of epidermal growth factor receptor gene by the hepatitis B virus X-gene product. Virology 196:878-882. 19. Murakami S, Cheong JH, Kaneko S. 1994. Human hepatitis virus X gene encodes a regulatory domain that represses transactivation of X protein. J. Biol. Chem. 269:15118-15123. 20. Nakatake H, Chisaka O, Yamamoto S, Matsubara K, Koshy R. 1993. Effect of X protein on transactivation of hepatitis B virus promoters and on viral replication. Virology 195:305-314. 21. Park OY, Jin YH, Lee M, Shin HJ, Kim HI, Cho H, Yun CW, Youn JK, Park S. 2000. Characterization and gene cloning of monoclonal antibody specific for the hepatitis B virus X protein. Hybridoma 19:73-80. 22. Passman M, Weinberg M, Kew M, Arbuthnot P. 2000. In situ demonstration of inhibitory effects of hammerhead ribozymes that are targeted to the hepatitis Bx sequence in cultured cells. Biochem. Biophys. Res. Commun. 268:728-733. 23. Petzold DR, Tautz B, Wolf F, Drescher J. 1999. Infection chains and evolution rates of hepatitis B virus in cardiac transplant recipients infected nosocomially. J. Med. Virol. 58:1-10. 24. Renner M, Haniel A, Burgelt E, Hofschneider PH, Koch W. 1995. Transactivating function and expression of the X gene of hepatitis B virus. J. Hepatol . 23:53-65. 25. Seto E, Michell PJ, Yen TSB. 1990. Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature 344:72-74. 26. Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D, Brechot C. 1999. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene 18:4848-4859. 27. Stemler M, Weimer T, Tu ZX, Wan DF, Levrero M, Jung C, Pape GR, Will H. 1990. Mapping of B-cell epitopes of the human hepatitis B virus X protein. J. Virol. 64:2802-2809. 28. Sung JL, and Chen DS. 1978. Clustering of different subtypes of hepatitis B surface antigen in families of patients with chronic liver diseases. Am. J. Gastroenterol. 69:559-564. 29. Tai PC, Banik D, Lin GI, Pai S, Pai K, Lin MH, Yuoh G, Che S, Hsu SH, Chen TC, Kuo TT, Lee CS, Yang CS, Shih C. 1997. Novel and frequent mutations of hepatitis B virus coincide with a major histocompatibility complex class I-restricted T-cell epitope of the surface antigen. J. Virol. 71:4852-4856. 30. Takada S, Kaneniwa N, Tsuchida N, Koike K. 1997. Cytoplasmic retention of the p53 tumor suppressor gene product is observed in the hepatitis B virus X gene-transfected cells. Oncogene 15: 1895-1901. 31. Tamori A, Nishiguchi S, Kubo S, Koh N, Moriyama Y, Fujimoto S, Takeda T, Shiomi S, Hirohashi K, Kinoshita H, Otani S, Kuroki T. 1999. Possible contribution to hepatocarcinogenesis of X transcript of hepatitis B virus in Japanese patients with hepatitis C virus. Hepatology 29: 1429-1434. 32. Tiollais P, Pourcel C, Dejean A. 1985. The hepatitis B virus. Nature 317: 489-495. 33. Twu JS, Lai MY, Chen DH, Robinson WS. 1993. Activation of protooncogene C-jun by the x protein of hepatitis B virus. Viroloy 192: 346-350. 34. Yeh CT, Shen CH, Tai DI, Chu CM, Liaw YF. 2000. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma. Oncogene 19: 5213-5220. 35. Yen TSB. 1996. Hepadnaviral X protein: review of recent progress. J. Biomed. Sci. 3: 20-30. 36. Zhang MT, Liu KZ, Jin JH, Ding LM, Zhou SC, Yu QY, Zhang XZ. 1993. Five-year follow-up of immune response to hepatitis B vaccine in juveniles. Chin. Med. J. 106:97-99. 37. Zhang Z, Torii N, Furusaka A, Malayaman N, Hu Z, Liang TJ. 2000. Structural and functional characterization of interaction between hepatitis B virus X protein and the proteasome complex. J. Biol. Chem. 275: 15157-15165.
|